Comparative Effects of Glibenclamide and Metformin on C-Reactive Protein and Oxidant/Antioxidant Status in Patients with Type II Diabetes Mellitus

Comparative Effects of Glibenclamide and Metformin on C-Reactive Protein and Oxidant/Antioxidant Status in Patients with Type II Diabetes Mellitus

Show other versions (1)

Objectives: This study aimed to compare the effects of metformin and glibenclamide on high sensitivity serum C-reactive protein (hs-CRP) and oxidative stress, represented by serum malondialdehyde (MDA) and total antioxidant status (TAS) in newly-diagnosed patients with Type 2 diabetes mellitus (DM)...

Full description

Bibliographic Details
Main Authors:	Alaa A.A. Abdulkadir, Imad A-J. Thanoon
Format:	Article
Language:	English
Published:	Sultan Qaboos University 2012-02-01
Series:	Sultan Qaboos University Medical Journal
Subjects:	Diabetes mellitus Metformin Glibenclamide Malondialdehyde (MDA) Total antioxidant status (TAS) High sensitivity serum C-reactive protein (hs-CRP)
Online Access:	http://web.squ.edu.om/squmj/includes/tng/pub/tNG_download.asp?id=92f5b8e4030451111446764d276b1dac

Similar Items

Comparative Effects of Glibenclamide and Metformin on C-Reactive Protein and Oxidant/Antioxidant Status in Patients with Type II Diabetes Mellitus
by: Alaa A.A. Abdulkadir, et al.
Published: (2012-02-01)

Study of serum Ceruloplasmin, Malondialdehyde (MDA) and hs-CRP as biomarkers of severity in Psoriasis
by: 1. K Prashanth, Assistant Professor, Department of Biochemistry, Rajiv Gandhi Institute of Medical Sciences [RIMS], Adilabad, Telangana State, India. 2. MohdInayatulla Khan, Assistant Professor, Department of Physiology, Rajiv Gandhi Institute of Medical Sciences [RIMS], Adilabad, Telangana State, India.
Published: (2020-12-01)

Effects of different doses of zinc gluconate on antioxidative activity of metformin and glibenclamide on experimentally induced diabetes in rabbits
by: Stanojević-Ristić Zorica, et al.
Published: (2017-01-01)

Antioxidant Protective Effect of Glibenclamide and Metformin in Combination with Honey in Pancreas of Streptozotocin-Induced Diabetic Rats
by: Omotayo Owomofoyon Erejuwa, et al.
Published: (2010-05-01)

Glibenclamide Mimics Metabolic Effects of Metformin in H9c2 Cells
by: Barbara Salani, et al.
Published: (2017-09-01)

Comparison of Antioxidant Effects of Honey, Glibenclamide, Metformin, and Their Combinations in the Kidneys of Streptozotocin-Induced Diabetic Rats
by: Mohd Suhaimi Ab Wahab, et al.
Published: (2011-01-01)

Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial
by: Rebecca M. Reynolds, et al.
Published: (2017-09-01)

Comparison of inflammation and oxidative stress levels by the severity of obesity in prepubertal children
by: Ni Luh Putu Surya Candra Eka Pertiwi, et al.
Published: (2018-01-01)

Determination of glibenclamide, metformin hydrochloride and rosiglitazone maleate by reversed phase liquid chromatographic technique in tablet dosage form
by: Havele Shweta S., et al.
Published: (2014-01-01)

Correlation of Serum Levels of Vitronectin, Malondialdehyde and Hs-CRP With Disease Severity in Coronary Artery Disease
by: Alireza Yaghoubi, et al.
Published: (2015-09-01)

EFFICANCY OF GLIBENCLAMIDE FOR THE CONTROL OF GESTATIONAL DIABETES MELLITUS
by: Quddsia Tanveer, et al.
Published: (2015-03-01)

Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone
by: Zita Wachal, et al.
Published: (2020-03-01)

Investigation And Comparison Of The Effect Of Saffron Petals Hydroalcoholic Extract With Metformin And Glibenclamide On Serum Glucose, HbA1c And Insulin Levels In Streptozotocin-Induced Diabetic Rats
by: Mansour Amraei, et al.
Published: (2018-10-01)

Spectrofluorimetric method for the determination of glibenclamide in pharmaceutical formulations
by: Baghdad Science Journal
Published: (2012-06-01)

Psoriasis, An inflammatory condition associated with oxidative stress
by: Swati Pal, et al.
Published: (2021-04-01)

Gestational diabetes mellitus—right person, right treatment, right time?
by: Robert S. Lindsay, et al.
Published: (2017-08-01)

Haemostasiologic effects of various glucose-lowering medications in type 2 diabetes mellitus
by: G. G. Petrik, et al.
Published: (2010-04-01)

Toxic effects of glibenclamide in fetuses of normoglycemic rats: an alternative therapy for gestational diabetes mellitus
by: L. Aguillar-Gomes, et al.
Published: (2014-05-01)

Changes in the pharmacokinetics of glibenclamide in rats with streptozotocin-induced diabetes mellitus
by: Yuqing Li, et al.
Published: (2012-04-01)

Dissolution test for glibenclamide tablets
by: Elisabeth Aparecida dos Santos Gianotto, et al.
Published: (2007-10-01)

Comparative evaluation of role of hs C -reactive protein as a diagnostic marker in chronic periodontitis patients
by: Shivangi Gupta, et al.
Published: (2020-01-01)

Correlation of high sensitive C-reactive protein and Hepatitis C Virus RNA in anti-HCV-positive sera
by: Tuncer Ozekinci, et al.
Published: (2011-06-01)

Oxidative stress/lipid peroxidation and antioxidant enzymes in apparently healthy individuals involved in physical exercise
by: Ikekpeazu Joy Ebele
Published: (2016-10-01)

Comparison of glibenclamide and insulin on neonatal outcomes in pregnant women with gestational diabetes
by: Mitra Behrashi, et al.
Published: (2016-01-01)

Determination of structural properties in the adsorption of drugs on chitosan-hydrogels for type 2 diabetes by means of the PM6 method
by: Nancy Liliana Delgadillo Armendariz, et al.
Published: (2020-05-01)

Glibenclamide therapy: pros and cons
by: Olga Konstantinovna Vikulova, et al.
Published: (2011-09-01)

Analysis of the changes of serum lipid and hs-CRP in patients with subclinical hypothyroidism
by: Jin-Mian Fan, et al.
Published: (2016-05-01)

Investigating the Relationship between hs-CRP Serum Level and Insulin Resistance (HOMA IR) Six Weeks after Childbirth in Patients with Gestational Diabetes Mellitus
by: Mozayyan SH, et al.
Published: (2017-02-01)

High sensitivity C-reactive protein as a predictive of intima-media thickness in patients with end-stage renal disease on regular hemodialysis
by: Lestariningsih L, et al.
Published: (2019-06-01)

Association of high sensitive C-reactive protein with coronary heart disease: a Mendelian randomization study
by: Qian Zhuang, et al.
Published: (2019-11-01)

Encapsulation and release characteristics of glibenclamide loaded calcium-alginate beads
by: Dalia Charles-Navarro, et al.
Published: (2010-01-01)

EFFECT OF HYDROXYETHYLCELLULOSE ON THE RELEASE OF GLIBENCLAMIDE FROM SUSTAINED RELEASE TABLETS
by: S. V. Trofimov
Published: (2019-01-01)

Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease
by: Klempfner Robert, et al.
Published: (2012-06-01)

Polymeric Microparticles as Alternative Carriers for Antidiabetic Glibenclamide Drug
by: Panoraia I. Siafaka, et al.
Published: (2019-11-01)

Ocena wartości rokowniczej osoczowego stężenia białka C-reaktywnego oznaczonego metodą o wysokiej czułości (hs-CRP) u chorych z przewlekłą niewydolnością serca = Usefulness of serum high-sensitivity C-reactive protein (hs-CRP) level as prognostic factor in patients with chronic heart failure
by: Daniel Rogowicz, et al.
Published: (2016-07-01)

Effects of glibenclamide on memory retention of passive avoidance learning in rats
by: MH. Esmaeili, et al.
Published: (2017-08-01)

Oral anti-diabetics for gestational diabetes mellitus – where do we stand?
by: Delia Cudalba, et al.
Published: (2020-09-01)

Hemostasis effects of various glucose-lowering medications and angiopathy prevention
by: G. G. Petrik, et al.
Published: (2011-06-01)

Glibenclamide in aneurysmatic subarachnoid hemorrhage (GASH): study protocol for a randomized controlled trial
by: Bruno Braga Sisnando da Costa, et al.
Published: (2019-07-01)

The effect of L-Carnitine supplementation on clinical symptoms, C-reactive protein and malondialdehyde in obese women with knee osteoarthritis: a double blind randomized controlled trial
by: Farnaz Baghban, et al.
Published: (2021-02-01)